PET-CT in oncological patients: analysis of informal care costs in cost-benefit assessment

Radiol Med. 2014 Apr;119(4):283-9. doi: 10.1007/s11547-013-0340-5. Epub 2013 Nov 26.

Abstract

Purpose: The authors analysed the impact of nonmedical costs (travel, loss of productivity) in an economic analysis of PET-CT (positron-emission tomography-computed tomography) performed with standard contrast-enhanced CT protocols (CECT).

Materials and methods: From October to November 2009, a total of 100 patients referred to our institute were administered a questionnaire to evaluate the nonmedical costs of PET-CT. In addition, the medical costs (equipment maintenance and depreciation, consumables and staff) related to PET-CT performed with CECT and PET-CT with low-dose nonenhanced CT and separate CECT were also estimated.

Results: The medical costs were 919.3 euro for PET-CT with separate CECT, and 801.3 euro for PET-CT with CECT. Therefore, savings of approximately 13% are possible. Moreover, savings in nonmedical costs can be achieved by reducing the number of hospital visits required by patients undergoing diagnostic imaging.

Conclusions: Nonmedical costs heavily affect patients' finances as well as having an indirect impact on national health expenditure. Our results show that PET-CT performed with standard dose CECT in a single session provides benefits in terms of both medical and nonmedical costs.

MeSH terms

  • Contrast Media / economics
  • Cost-Benefit Analysis
  • Costs and Cost Analysis*
  • Efficiency
  • Female
  • Fluorodeoxyglucose F18 / economics
  • Humans
  • Italy
  • Male
  • Middle Aged
  • Multimodal Imaging / economics*
  • Positron-Emission Tomography / economics
  • Radiopharmaceuticals / economics
  • Surveys and Questionnaires
  • Tomography, X-Ray Computed / economics
  • Travel / economics

Substances

  • Contrast Media
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18